Caesarean section and antiretroviral treatment

Lancet

Volumn 355, Issue 9202, 2000, Pages 496-

  Ricci, E ^a   Parazzini, F ^a,b   Pardi, G ^a  

^a SAN PAOLO HOSPITAL   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ZIDOVUDINE;

CESAREAN SECTION; DRUG EFFICACY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MAJOR CLINICAL STUDY; NEWBORN; PRIORITY JOURNAL; VAGINAL DELIVERY; VERTICAL TRANSMISSION;

EID: 0034606952     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)82051-6     Document Type: Letter

References (2)

1. The European Mode of Delivery Collaboration. Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial Lancet 353 1999 1035 1039
2. Grubert TA Reindell D Kästner R Lutz-Friedrich R Belohradsky BH Dathe O Complications after caesarean section in HIV-1-infected women not taking antiretroviral treatment Lancent 354 1999 1612 1613